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To evaluate the screening performance of individual and combined use of clinical breast examination,
ultrasonography and mammography in Chinese women, we conducted a biennial breast cancer screening program
among 14,464 women aged 35 to 74 years old who lived in Qibao County, Minhang district of Shanghai, China,
between May 2008 and Sept 2012. All participants were submitted to clinical breast examination, and then women
with positive results and all women at age of 45-69 years old were preformed breast ultrasonography and
mammography. The examination results were compared against pathological findings as the gold standard of
reference. A total of 66 women were diagnosed with breast cancer in the two rounds of the screening, yielding an
incident rate of 194 per 100,000 person-years. The sensitivity of clinical breast examination, ultrasonography and
mammography alone were 61.4%, 53.7% and 67.3%, respectively. While mammography performed better in elder
age groups and hormone receptor positive disease groups, ultrasonography had a higher sensitivity in younger age
group and did not differ in sensitivity by estrogen receptor or progesterone receptor status. Combined use of the
two imaging examinations increased the sensitivity in almost all age groups, but had a higher sensitivity in
hormone receptor positive cancers than in those negative. Our results suggest that the Qibao modality is an
effective strategy for breast cancer screening among Chinese women, especially for early detection of elder and
hormone receptor positive breast cancer.
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Breast cancer is the most common malignancy among
women around the world. It is estimated that, in 2008,
1.38 million women were newly-diagnosed with breast
cancer and 458,000 died of the malignancy (Ferlay et al.
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in any medium, provided the original work is ptranslation in lifestyles in China, breast cancer has been
becoming one of the leading public health issues in the
country. In Shanghai, the biggest city in China, the over-
all age-adjusted incidence increased by 134% between
1975 and 2004 (Shanghai Municipal Center for Disease
Control and Prevention 2007).
So far, no effective approach has been developed to
prevent the incidence of breast cancer. Therefore, early
detection of the malignancy is of the most important to
improve the life of quality, prolong the survival of pa-
tients and prevent the premature death from the disease.
During past decades, while both incidence and mortality
of breast cancer have been rising in China and otherpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Screening modality of breast cancer in the SBSP.
Mo et al. SpringerPlus 2013, 2:276 Page 2 of 8
http://www.springerplus.com/content/2/1/276Asian countries (Shin et al. 2010), the mortality of the
disease has decreased in the West although the inci-
dence also has been increasing (Hermon et al. 1996;
Tabar et al. 1985). Besides the improvement of treatment
(Burton et al. 2012), early detection of breast cancer has
been suggested to be one of the most important contrib-
utors (Narod 2011; Smith et al. 2012).
Mammography (MAM) screening plays a central role
in early detection of breast cancers in western countries.
Multiple population-based randomized controlled trials
(RCTs) of MAM screening have individually and collect-
ively provided strong support for the efficacy of breast
cancer screening (Gotzsche et al. 2011). Based on these
RCTs and observational studies, different screening
guidelines have been established due to different inter-
pretations of the evidence (Tonelli et al. 2011). Although
contentious academic debates exist over the balance of
benefits and potential harms from MAM (No authors
listed. 2011), mass screening of breast cancer has be-
come a routine practice in many Western countries (US
Preventive Services Task Force 2009; Smith et al. 2003).
Comparing with their western counterparts, Chinese
women have a relatively lower risk of breast cancer.
Chinese women tend to have small, dense breasts, which
may reduce the sensitivity of MAM. Moreover, while the
incidence of breast cancer shows a linear relationship
with age in Western women, the peak incidence of the
disease has been observed among Chinese women at
ages of 45 and 49 years old (Leong et al. 2010). There-
fore, the recommended MAM screening strategy in the
West may not be practical in China. Recent years, ultra-
sonography (US), as a supplementary examination to
MAM, has been suggested to improve the diagnostic per-
formance of the imaging procedures in clinical practice,
particularly among Asian women (Xiao et al. 2008). Evi-
dence from community population, however, is lacking.
In this study, by taking advantage of the data from the
Shanghai Society-based Breast Screening Program (SBSP)
initiated in May 2008, a biennial mass screening of breast
cancer designed based on recommended screening strat-
egies in Western countries and the experience in clinical
practice, we evaluated the performance of screening
methods and screening modality, aiming at seeking an op-
timal breast cancer screening modality in Chinese women.
Materials and methods
Screening program and participants
This SBSP was conducted among Chinese women aged
35-74 years old in three consecutive stages. As shown in
Figure 1, at first stage all eligible women living in Qibao
county, Minhang district of Shanghai, were asked to be
interviewed using a structured questionnaire and had a
CBE after signing a consent form. The questionnaire in-
cluded questions on demography characteristics, menstrualand reproductive factors, family history of breast cancer
and history of any benign breast lesions. Women with
positive CBE results and women at age of 45-69 years old,
regardless of the CBE results, were preformed US and
MAM examination in Cancer Hospital of Fudan University
(second stage). Women either US positive or MAM posi-
tive had breast biopsy at the hospital (third stage). Breast
cancer was diagnosed based on biopsy or pathological
examination after surgery. Subjects with suspicious result
of biopsy were recommended to take the next round of
imaging examination.
During the period of May 2008 to September 2012,
two rounds of breast cancer screening were conducted.
Of the 14,464 women participating in the program, 2,117
(15%) only participated in the 2nd round of screening. A
total of 64 subjects were detected as breast cancer in this
program and 2 were identified by conducting record link-
age with the Shanghai Cancer Registry System. This study
was approved by the institutional ethics committee of
Fudan University (Approval #: 20080460-5).
Screening methods
CBE, MAM and US were used as screening methods in
the SBSP. CBE was conducted by experienced surgeons
in Qibao community hospital. Imaging screening was
performed at the Breast Diagnostic Center in Cancer
Hospital of Fudan University, which had staff facilities
including surgeons, physicians, radiologists and patholo-
gists. The MAM radiologists and the US operators
completed respective imaging reports independently and
were blinded to each other’s report.
In digital MAM (GE, 2000DTM (SD) or LORAD), ex-
posure controls of MAM units were set at 25 kV with
film density between 1.6 and 1.8D and daily calibration.
Lateral image of each breast was obtained on two films
(CC and MLO). The data were digitally stored and backed-
up once a year. The films of MAM on high-resolution
screen (BARCO) were read and interpreted independently
by two radiologists following the Breast Imaging Reporting
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College of Radiology (ACR).
The Doppler US images with high-frequency transduc-
ers at 7.5–10 MHz were obtained by two operators who
did both the scanning and interpreting. The US opera-
tors scanned in vertical and horizontal parallel stripes
covering the breast, axillary tail, and areola region, en-
suring that each side of the entire breast volume was
scanned twice. Axillary region was routinely scanned re-
gardless of whether there was a significant abnormality
in the ipsilateral breast. The daily workload of each US
operator was restricted to fewer than 40 cases and
average time per case was at least 5 min to guarantee
the screening quality. Images of concerning lesions wereTable 1 Incidence of breast cancer by characteristics of the p
Characteristics No. of subjects No. of
All subjects 14464 6
Age (yrs.)






Primary school or No formal education 3324 1
Junior middle school 5646 1
Senior high school or technical school 3739 2
Junior college 1018 6
Regular college or above 737 4
Family history of breast cancer
Yes 366 5
No 14098 6
Age at menarche (yrs.)
≤ 13 2078 1
14-17 10330 4




Age at menopause (yrs.)
< 45 721 4
45-54 8323 4
≥ 55 952 6
Age at first live birth (yrs.)
Nulliparity 299 0
< 24 3290 1
24-29 9121 3
≥ 30 1750 1
Missing values were excluded from the analysis (3 subjects for age at menarche, 13taken specifically. The determination of a malignant le-
sion was based on ACR BI-RADS.
Statistical analysis
All statistical analysis was performed using SAS soft-
ware (version 9.2). We censored observational date on
September 1, 2012. Thus, the years of exposure were
computed from the date of examination (CBE or
2imaging screening) to the date of diagnosis or death, or
the date of end. The sensitivity of a certain screening
method was defined as the number of subjects correctly
classified as breast cancers by this method divided by
the number of all malignant cases diagnosed, and speci-
ficity was the ratio of true negatives by the method to allarticipants of the SBSP
cases Person years Incidence (/100,000 PYs) HR (95% CI)
6 34001 194 —
2122 0 —
6848 131 0.60 (0.28, 1.27)
9 13200 220 1.00 (ref.)
3 9712 237 1.07 (0.62, 1.85)
2118 236 1.05 (0.40, 2.72)
7 8940 190 1.23 (0.62, 2.44)
8 13361 135 1.00 (ref.)
1 8099 259 1.86 (0.99, 3.49)
2148 279 2.44 (0.96, 6.19)
1454 275 2.91 (0.97, 8.72)
858 583 3.03 (1.22, 7.54)
1 33143 184 1.00 (ref.)
5 4582 327 1.99 (1.10, 3.58)
4 24273 181 1.00 (ref.)
5142 136 0.66 (0.29, 1.47)
2 10510 114 0.81 (0.32, 2.04)
4 23462 230 1.00 (ref.)
1704 235 1.12 (0.41, 3.11)
4 19523 225 1.00 (ref.)
2234 269 1.20 (0.51, 2.81)
643 0 —
3 7940 164 0.99 (0.51, 1.92)
9 21691 180 1.00 (ref.)
4 3718 377 2.01 (1.09, 3.71)
for menopause status and 4 for age at first live birth).
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as the number of true positive divided by the total
number of subjects who tested positive, and negative
predictive value (NPV) referred to the proportion of
subjects with a negative test result who were correctly
diagnosed. χ2 test or Fisher’s exact test was used to com-
pare the clinicopathological characteristics between
screened and interval cancers, and diagnostic perform-
ance between different screening methods. Cox model
was used to compute the hazard ratios (HR) and 95%
confidential interval (CI) of risk factors of breast cancer.
P < 0.05 was considered as statistically significant for
two-sided tests.
Results
Incidence of breast cancer by characteristics of the
participants
As presented in Table 1, the overall incidence of breast
cancer was 194 per 100,000 person-years. The incidence
was significantly higher in women with a family history,
earlier age at menarche or older age at first live birth.
Age, higher education and older age at menopause were
also related to breast cancer risk, but the HRs did not
reach significant.
Figure 2 shows the age-specific incidence of breast
cancer among the participants of the SBSP and the non-
participants living in Minhang district whose incidence
was from the Shanghai Cancer Registry system. A much
higher breast cancer incidence was observed among
participants of either the 1st round or the both rounds
of screening than in non-participants. Interestingly, the
peak incidence was observed among women around
45 years old in non-participants while the incidence in-
creased with age among the participants, particularly for
those participating in the 1st round of screening.Figure 2 Comparison of age-specific incidence of breast cancer betwComparison of characteristics of detected and interval
breast cancer cases
64 of 66 breast cancer cases were detected within two
years of the last screening examination. As shown in
Table 2, 51 cases were found during the 1st round of
screening and 13 during the 2nd round of detecting. A
total of 13 cases (20.3%) were interval cancer, namely,
being diagnosed in two years but after three months of
the imaging examinations. The percentage of interval
cancer was higher in the age-group of 50-59 years, and
among those with ER or PgR negative status, although
the difference was not significant. The interval cancer
also tended to be invasive ductal carcinomas and with
large lump size.
Performances of screening methods and modality
Among 14,464 participants, 13,906 subjects had CBE.
The sensitivity of CBE alone was 61.4%, slightly higher
than that of the US alone (53.7%). However, CBE showed
quite lower specificity (51.5%) and PPV (0.5%) than US
(98.5% and 17.4%, respectively). MAM had higher sensi-
tivity (67.3%) and PPV (17.9%) than did US alone. When
combining US and MAM in screening, the sensitivity in-
creased to 79.3% (Table 3).
The three-stage Qibao modality was not conducted
strictly in practice. About 30% of participants who should
be subjected to imaging examination lacked US or MAM
imaging result, and about 300 participants had unneces-
sary imaging examinations according to the screening
strategy. The changes have resulted in a slightly lower
sensitivity (75.4%) than the modality (76.0%), which was
calculated among 9,994 women following the Qibao
screening modality strictly.
Table 4 presents the performance of US and MAM
screening by age groups. US alone had highest sensitivityeen participants and non-participants of the SBSP.
Table 2 Clinicopathological characteristics of breast cancer cases in the SBSP
Characteristics 1st round screening 2nd round screening Total
No. of cases Interval cases (N, %) No. of cases Interval cases (N, %) No. of cases Interval cases (N, %)
Overall 51 11 (21.6) 13 2 (15.4) 64 13 (20.3)
Age group
40- 6 0 3 0 9 0
50- 25 7 (28.0) 3 1 (33.3) 28 8 (28.6)
60- 16 3 (18.8) 6 1 (16.7) 22 4 (18.2)
70- 4 1 (25.0) 1 0 5 1 (20.0)
Pathological type
DCIS 8 2 (25.0) 0 0 8 2 (25.0)
DCIS with micro-invasive 5 1 (20.0) 2 0 7 1 (14.3)
IDC 34 6 (17.7) 9 1 (11.1) 43 7 (16.3)
Special types 3 2 (66.7) 2 1 (50.0) 5 3 (60.0)
Size (mm)
DCIS 13 3 (23.1) 3 0 16 3 (18.8)
< 20 12 3 (25.0) 5 2 (40.0) 17 5 (29.4)
20- 23 4 (17.4) 4 0 27 4 (14.8)
50- 2 1 (50.0) 0 0 2 1 (50.0)
Axillary lymph node status
Negative 40 10 (25.0) 12 2 (16.7) 52 12 (23.1)
Positive 10 1 (10.0) 0 0 10 1 (10.0)
Stage
DCIS a 13 3 (23.1) 3 0 16 3 (18.8)
I 15 3 (20.0) 8 2 (25.0) 23 5 (21.7)
IIA 14 3 (21.4) 1 0 15 3 (20.0)
IIB 6 1 (16.7) 0 0 6 1 (16.7)
III-IV 2 1 (50.0) 0 0 2 1 (50.0)
ER status
Positive 35 7 (20.0) 9 2 (22.2) 44 9 (20.5)
Negative 13 4 (30.8) 3 0 16 4 (25.0)
PgR status
Positive 30 4 (13.3) 9 2 (22.2) 39 6 (15.4)
Negative 18 7 (38.9) 3 0 21 7 (33.3)
a both DCIS and DCIS with micro-invasive;
Missing values were excluded from the analysis (1 for pathological type, 2 for tumor size, axillary lymph node status and stage, 4 for ER and PgR status).
Abbreviations: DCIS ductal carcinoma in situ, IDC invasive ductal carcinoma, ER estrogen receptor, PgR progesterone receptor.
Table 3 Overall screening performance of screening methods in the SBSP
Screening methods No. of tests No. of patients Sensitivity (%) Specificity (%) PPV (%) NPV (%)
CBE 13906 57 61.4 51.5 0.5 99.7
US 9261 54 53.7 98.5 17.4 99.7
MAM 9238 55 67.3 98.1 17.9 99.8
US + MAM 9226 53 79.3 96.9 12.8 99.9
Screening modality a 9994 50 76.0 97.2 12.1 99.9
Real practice of the modality 13906 57 75.4 81.3 1.6 99.9
a Among women following the Qibao screening modality strictly.
Abbreviations: CBE: clinical breast examination; US: ultrasonography; MAM: mammography.
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Table 4 Performance of US and MAM screening by age







Sensitivity (%) PPV (%)
US
Age group
< 45 651 4 75.0 25.0
45-59 5261 25 52.0 14.0
60-69 3128 21 52.4 20.4
≥70 221 4 50.0 25.0
MAM
Age group
< 45 644 4 50.0 18.2
45-59 5255 26 65.4 13.4
60-69 3119 21 66.8 22.6
≥70 220 4 100.0 57.1
US + MAM
Age group
< 45 644 4 75.0 15.0
45-59 5245 24 70.8 8.7
60-69 3117 21 85.7 17.7
≥70 220 4 100.0 33.3
Abbreviations: US ultrasonography, MAM mammography, PPV positive
predictive value.
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group (50%). Conversely, MAM alone performed best in
the oldest group and had lowest sensitivity in the youn-
gest group (50.0%). Combined use of the two imaging
examinations improved sensitivity in almost all age
groups and increased the sensitivity as high as 85.7% in
the group of 60-69 years old.
As presented in Table 5, among 60 breast cancer cases
having ER and PgR status data, the sensitivity of US
alone was comparable between ER or PgR positive and
negative patients. MAM, on the other hand, had a
higher sensitivity among ER or PgR positive patients.
The difference between PgR positive and negative pa-
tients reached significant (P = 0.02). The combined use
of the two imaging examinations improved the sensitiv-
ity of screening regardless of ER or PgR status, but had
a higher sensitivity in hormone receptor (ER and PgR)
positive cancers than in those negative (90.0% vs. 63.2%,




Positive Negative P value Positive
US 52.8% (19/36) 50.0% (7/14) 0.86 51.6% (16/31)
MAM 72.2% (26/36) 53.3% (8/15) 0.19 78.1% (25/32)
US + MAM 82.9% (29/35) 71.4% (10/14) 0.44 90.3% (28/31)
Abbreviations: ER estrogen receptor, PgR progesterone receptor, US ultrasonographPotential adjustment of the Qibao screening modality
Based on the age-specific sensitivity of the screening
methods in this population, we adjusted the screening
modality to improve the effectiveness of screening or
minimize the workload. If the age-group of the women
having CBE, US and MAM was adjusted from 45-69 to
50-69 years old, the sensitivity would remain unchanged
but the costs for 334 times of MAM and US could be
saved. Alternatively, if all women over 70 years old with
CBE positive results had MAM alone instead of having
both MAM and US, the costs for 107 times of US could
be saved without loss of effectiveness.
Discussion
Based on recommended screening strategies in Western
countries (No authors listed 2009; Smith et al. 2003) and
screening experiences in other countries (Shetty 2011;
Uchida et al. 2008), our current population-based breast
cancer screening program conducted in Qibao county of
Minhang district in Shanghai, China, was designed to
combined use of MAM and US to early detect breast can-
cer in Chinese women. Considering the large population
and limited resources in China, clinical breast examin-
ation (CBE) was also used as one of screening methods,
which has been suggested as a good candidate for early
detecting of breast cancer in developing countries like
India and China (Jatoi 2003).
After two rounds of biennial screening, the incidence
of breast cancer was much higher in participants than in
non-participants. It also appears increase dramatically
compared with the age-specific incidence rates in gen-
eral female population of Shanghai, China (Shanghai
Municipal Center for Disease Control and Prevention
2010; Shanghai Municipal Center for Disease Control
and Prevention 2011). The incidence pattern by age-
groups was greatly changed by the screening program.
In non-participants, the incidence remained stable along
age with a small peak around 45 years old, which is similar
to the patterns observed in Asian women (Lee et al. 2009;
Tonelli et al. 2011). In the participants, conversely, the in-
cidence increased with increasing age, which is very close
to the patterns in western countries (Lee et al. 2009). Early
detection of breast cancer, particularly the 1st round of
screening, may be the main reason for the change. That is,
some patients who would be diagnosed naturally lateratus in the SBSP
R status ER and PgR status
Negative P value Both positive Either negative P value
52.6% (10/19) 0.94 53.3% (16/30) 50.0% (10/20) 0.82
47.4% (9/19) 0.02 77.4% (24/31) 50.0% (10/20) 0.04
61.1% (11/18) 0.03 90.0% (27/30) 63.2% (12/19) 0.03
y, MAM mammography.
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cidence rate. However, due to that 2.5% of participants in
our population had family history of breast cancer, much
higher than 1.4% in the general population of Shanghai
(DeRoo et al. 2010), selection bias could not be excluded.
Many factors may influence the accuracy of the screen-
ing methods. The performance of CBE mainly depends on
the operator’s skills and experience. In this program, the
CBE was conducted by several skilled and experienced
surgeons, making the overall sensitivity as high as 61.4%.
However, the specificity and PPV of CBE were quite lower
than other screening methods. MAM alone shows a lower
sensitivity in this population than it did in other ethnic
populations (Mushlin et al. 1998), possibly due to smaller
and denser breasts in Asian women. However, we find
that, along with increasing age the sensitivity of MAM in-
creased while that of US decreased, as a result combined
use of the two methods greatly improved the overall diag-
nostic sensitivity, consistently with the findings in com-
munities and in clinical practice (Ji et al. 2013). We also
find that the hormone receptor status of breast cancer in-
fluence the sensitivity of MAM, but not the accuracy of
US, providing further evidence for value of US as comple-
mentary tool to MAM in breast cancer screening among
Chinese women.
The Qibao screening modality was designed to use
different screening methods combinedly and focus on
Chinese women possibly at high risk of the disease.
Based on the age-specific incidence and age-specific sen-
sitivity of different screening methods in this population,
we find that the adjustment in age-group at high risk
and the modification of screening methods can save
costs for examination without trading off any effective-
ness. These results suggest that the Qibao screening mo-
dality can be further improved. Cost-effective analysis of
the program, however, is warranted to optimize and ex-
pand the use of the modality in China.
The strengths of the study included the representative
sample of community female residents, large sample size
and well-designed screening modality. However, only
two rounds of screening have completed, limiting the
statistical power in the analysis.
In conclusion, the Qibao modality is an effective strat-
egy for breast cancer screening in Chinese women. The
preliminary results of the first two rounds of screening
provide implications on how to further improve the ef-
fectiveness of screening in Chinese population.
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